About Fred
• Competitive Intelligence (CI) leader with 14+ years of pharma/ biotech industry experience, including over 6 anda half years specialising in oncology and immuno-oncology (IO) competitive intelligence, clinical data insights, evidence synthesis, and strategic analysis to inform evidence-based decision-making.
• 7+ years of experience in preclinical drug discovery.
• Deep domain expertise in oncology therapeutics (for solid tumours and haematological malignancies), covering a global pipeline, with acute understanding of several treatment modalities including antibody-drug conjugates, monoclonal antibodies, bispecifics, chemotherapy, hormonal therapy, cell therapy and small molecules.
• 7+ years of leadership experience on various dimensions, including team leadership, line managing direct reports, leading an IO CI function, expanding the scope and influence of an insights function, drug discovery project leadership, project management, stakeholder and external vendor management, hiring and mentoring junior colleagues, fostering capability building within a team, delegating work effectively, improving integrated insights processes (Six Sigma Yellow Belt), and driving adoption of new systems to improve evidence-based decision-making and maximise the strategic value of competitor information.
• Proven track record of collaborating with senior leadership (Senior Director, VP and C-suite) and other key partners from several functions (medical, clinical development, Business Development, publications, and InvestorRelations), to deliver actionable insights, and support clinical trial planning, portfolio asset prioritisation, lifecycle management, and corporate strategy activities.
English
Native or bilingual
French
Native or bilingual
Can work on-site
Cambridge (up to 50km), London (up to 50km)
Experience
- ASTRAZENECASenior Clinical Information Science Specialist (Assoc Director level)PHARMACEUTICALS INDUSTRYNovember 2022 - February 2026 (3 years and 3 months)• Completed 4 consecutive contract assignments with expanding responsibilities, as part of the Oncology Biometrics Information Practice department (OMBIP), which purpose is to translate complex clinical information and scientific data into knowledge and actionable insights.• Collaborated cross-functionally on multiple process improvement and strategic projects successfully, consistently supporting senior leadership decision-making at increasing levels of complexity.• Led or contributed to several literature review, clinical trial data analysis, and evidence synthesis projects acrossmultiple oncology indications (with a focus on Lung and Breast cancer pipeline assets) to support clinical trial design, submissions, portfolio investment decisions, market sizing, and indication expansion initiatives for AstraZeneca's oncology and IO drugs pipeline, at many stages of the drug development lifecycle (preclinical through to• Designed and executed complex search strategies involving the use of various data sources, including Norstella suite (Trialtrove, Pharmaprojects), Clarivate tools (Cortellis, OFF-X, DRG), PubMed, Embase, Scopus, MEDLINE, conference databases, epidemiology databases (Kantar), Clinicaltrials.gov, and other clinical trial registries. Delivered high-quality reports to a wide range of cross-functional stakeholders.
- F-STAR THERAPEUTICSSenior Business Analyst Competitive Intelligence (Function Head)BIOTECHOctober 2020 - November 2022 (2 years and 1 month)• As the head of the CI function, I expanded the function's scope independently, to support more strategic and C-level initiatives, and to further integrate with the clinical development project teams.• Led and completed multiple high-priority literature review and clinical evidence reporting projects simultaneously within fast-paced environments while maintaining high standards of scientific accuracy and delivery quality.• Gathered information from literature and various external data sources to generate different types of insights, supporting decision-making for preclinical and early clinical programs as well as BD, corporate strategy, portfolio strategy, Investor Relations, and fundraising. Translated complex, unstructured preclinical, clinical, industry and market data into actionable insights and knowledge.• Data sources: GlobalData, Beacon Bispecifics (Hanson Wade), Alphasense, IR Insight, Reprints Desk (Article Galaxy), Clinicaltrial.gov, EU clinical trial register, GLOBOCAN, NIH, SEER, NCCR, Drugs@FDA, EMA Medicines, BioRxiv, MedRxiv, PubMed, Google alerts, Google Scholar, competitor websites, press releases, and 10-Ks/ 10-Qs.• Contributing to strategic planning and portfolio decisions. Led asset-specific clinical indication landscaping and visualisation. Conducted clinical competitors landscaping searches, data analysis and design of mapping visualisation for 2 oncology indication landscapes (SCCHN and NSCLC), synthesising complex and unstructured information into simple and easy-to-understand timeline-style visual slide decks. Enabled the C-suite and clinicaldevelopment program teams to have a single source of truth updated quarterly, streamlining governance discussions on pipeline asset positioning, trial planning and portfolio strategy, for the 2 leading clinical bispecific pipeline assets. Reduced preparation time for quarterly pipeline governance review meetings.
- F-STAR THERAPEUTICSBusiness Analyst Competitive IntelligenceBIOTECHOctober 2019 - October 2020 (1 year)• Launched a CI function from scratch in collaboration with the VP of Corporate Strategy and an intern. Allowed to solve a C-suite strategic gap in scientific/ clinical data search and analysis for evidence-based decision-making.• Strategic leadership. Established workflows, took ownership of the company's intelligence data source subscriptions and designed a long-term strategic roadmap for the CI function.• Collaborated with scientific, medical, translational, intellectual property, BD, investor relations, and C-suite stakeholders to support strategic decision-making based on scientific and clinical evidence.• Data sources proficiency: Beacon Wade), EU Google Google alerts, competitor websites, press releases, and 10-Ks/ 10-Qs.• Proactive prioritization. Managed competing requests from several functions in a fast-paced environment, prioritising delivery by the most senior stakeholders, initiatives with the highest strategic impact, and urgency.• Asset-specific IO target landscaping and visualisation. Led clinical indication landscaping and visualisation. Conducted clinical competitors landscaping searches, data analysis and design of mapping visualisation for 5 IOtarget landscapes (PD-1/L1, LAG-3, CD137, OX40, STING), synthesising complex and unstructured information into simple and easy-to-understand timeline-style visual slide decks. Enabled the C-suite and clinical development program teams to have a single source of truth updated quarterly, streamlining governance discussions on pipeline asset positioning, trial planning and portfolio strategy, for all clinical pipeline bispecific assets. Reduced preparation time for quarterly pipeline governance review meetings.
Recommendations
Be the first to recommend Fred
Help this freelancer shine by sharing your experience working together.
These freelancer profiles also match your criteria
Agatha Frydrych
Backend Java Software Engineer
4.7
(3)
2
Baptiste Duhen
Fullstack developer
4.6
(4)
5
Amed Hamou
Senior Lead Developer
4
(2)
7
Audrey Champion
Web developer
4.3
(3)
4
Education
- M.SC. IN PROTEIN ENGINEERINGUniversité Paul Sabatier2012M.SC. IN PROTEIN ENGINEERING
- B.SC. IN CHEMISTRY, BIOLOGY, PHYSICS, ANDUniversité Paul Sabatier2010B.SC. IN CHEMISTRY, BIOLOGY, PHYSICS, AND